Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Retrieval Practice in Patients With Schizophrenia : an Exploratory Study Using Descriptive Stories
Recruitment is currently suspended.
In Strasbourg
Role of Vitamin D Supplementation in First Episode Schizophrenia: A Double Blind Controlled Study
This study has finished and is no longer accepting participants.
In RanchiReal-time fMRI Feedback as a Tool to Mitigate Auditory Hallucinations in Schizophrenia
This study has finished and is no longer accepting participants.
In Brockton
Repetitive Transcranial Magnetic Stimulation (rTMS) as a Probe of Episodic Memory (EM) Neurocircuitry in Schizophrenia
This study has finished and is no longer accepting participants.
In IndianapolisResearchers compared Brexpiprazole and Aripiprazole to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
In Xi’anResearchers compared MP-214 3mg, MP-214 6mg, MP-214 9mg, Risperidone 4mg and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including SapporoSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 409306 Film-coated Tablets Given Orally q.d. for 14 Days in Patients With Schizophrenia (Randomized, Parallel-group, Double-blind, Placebo-controlled Study)
This study has finished and is no longer accepting participants.
In AustinResearchers studied Brexpiprazole, tracking side effects to assess long-term safety and tolerability in young people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including DothanResearchers compared RL-007 and placebo, tracking side effects to assess safety in people with schizophrenia.
This study has finished and is no longer accepting participants.
In Long BeachPhase II Study of MP-214 in Patients With Schizophrenia (Exploratory Study)
This study has finished and is no longer accepting participants.
In KureA Phase 1, Single Dose, Parallel Cohort Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TV-44749, Olanzapine for Extended-Release Injectable Suspension for Subcutaneous Use, in Chinese Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including BeijingOpen-Label Study in Stable Schizophrenia Patients to Evaluate the Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant (DLP-114)
This study has finished and is no longer accepting participants.
Multiple locations, including Long BeachWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.